Next Article in Journal
Genomic Mining Reveals Deep Evolutionary Relationships between Bornaviruses and Bats
Next Article in Special Issue
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
Previous Article in Journal / Special Issue
Oncolytic Replication of E1b-Deleted Adenoviruses
Article Menu

Export Article

Open AccessReview
Viruses 2015, 7(11), 5780-5791; doi:10.3390/v7112899

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

1
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck laboratory C11, Dag Hammarskjoldsvag 20, 75185 Uppsala, Sweden
2
Lokon Pharma AB, Dag Hammarskoldsvag 40c, 75183 Uppsala, Sweden
Academic Editors: Martine L. M. Lamfers and E. Antonio Chiocca
Received: 31 August 2015 / Revised: 16 October 2015 / Accepted: 16 October 2015 / Published: 6 November 2015
(This article belongs to the Special Issue Oncolytic Viruses)
View Full-Text   |   Download PDF [1526 KB, uploaded 6 November 2015]   |  

Abstract

Immunostimulatory gene therapy has been developed during the past twenty years. The aim of immunostimulatory gene therapy is to tilt the suppressive tumor microenvironment to promote anti-tumor immunity. Hence, like a Trojan horse, the gene vehicle can carry warriors and weapons into enemy territory to combat the tumor from within. The most promising immune stimulators are those activating and sustaining Th1 responses, but even if potent effects were seen in preclinical models, many clinical trials failed to show objective responses in cancer patients. However, with new tools to control ongoing immunosuppression in cancer patients, immunostimulatory gene therapy is now emerging as an interesting option. In parallel, oncolytic viruses have been shown to be safe in patients. To prolong immune stimulation and to increase efficacy, these two fields are now merging and oncolytic viruses are armed with immunostimulatory transgenes. These novel agents are racing towards approval as established cancer immunotherapeutics. View Full-Text
Keywords: oncolytic; adenovirus; gene therapy; immunotherapy; tumor immunology oncolytic; adenovirus; gene therapy; immunotherapy; tumor immunology
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Loskog, A. Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles. Viruses 2015, 7, 5780-5791.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top